Cargando…

Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19

BACKGROUND: Disease progression of subjects with coronavirus disease 2019 (COVID-19) varies dramatically. Understanding the various types of immune response to SARS-CoV-2 is critical for better clinical management of coronavirus outbreaks and to potentially improve future therapies. Disease dynamics...

Descripción completa

Detalles Bibliográficos
Autores principales: Richard, Dannebaum, Phillip, Suwalski, Hosseinali, Asgharian, Gracie, Du Zhipei, Hai, Lin, January, Weiner, Holtgrewe, Manuel, Charlotte, Thibeault, Melina, Müller, Xiaomin, Wang, Zehra, Karadeniz, Jacopo, Saccomanno, Jan-Moritz, Doehn, Ralf-Harto, Hübner, Bernd, Hinzmann, Anja, Blüher, Sandra, Siemann, Dilduz, Telman, Norbert, Suttorp, Martin, Witzenrath, Stefan, Hippenstiel, Carsten, Skurk, Wolfgang, Poller, Leif E, Sander, Dieter, Beule, Florian, Kurth, Toumy, Guettouche, Ulf, Landmesser, Jan, Berka, Khai, Luong, Rubelt, Florian, Bettina, Heidecker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106482/
https://www.ncbi.nlm.nih.gov/pubmed/35600330
http://dx.doi.org/10.1016/j.eclinm.2022.101438
_version_ 1784708295301267456
author Richard, Dannebaum
Phillip, Suwalski
Hosseinali, Asgharian
Gracie, Du Zhipei
Hai, Lin
January, Weiner
Holtgrewe, Manuel
Charlotte, Thibeault
Melina, Müller
Xiaomin, Wang
Zehra, Karadeniz
Jacopo, Saccomanno
Jan-Moritz, Doehn
Ralf-Harto, Hübner
Bernd, Hinzmann
Anja, Blüher
Sandra, Siemann
Dilduz, Telman
Norbert, Suttorp
Martin, Witzenrath
Stefan, Hippenstiel
Carsten, Skurk
Wolfgang, Poller
Leif E, Sander
Dieter, Beule
Florian, Kurth
Toumy, Guettouche
Ulf, Landmesser
Jan, Berka
Khai, Luong
Rubelt, Florian
Bettina, Heidecker
author_facet Richard, Dannebaum
Phillip, Suwalski
Hosseinali, Asgharian
Gracie, Du Zhipei
Hai, Lin
January, Weiner
Holtgrewe, Manuel
Charlotte, Thibeault
Melina, Müller
Xiaomin, Wang
Zehra, Karadeniz
Jacopo, Saccomanno
Jan-Moritz, Doehn
Ralf-Harto, Hübner
Bernd, Hinzmann
Anja, Blüher
Sandra, Siemann
Dilduz, Telman
Norbert, Suttorp
Martin, Witzenrath
Stefan, Hippenstiel
Carsten, Skurk
Wolfgang, Poller
Leif E, Sander
Dieter, Beule
Florian, Kurth
Toumy, Guettouche
Ulf, Landmesser
Jan, Berka
Khai, Luong
Rubelt, Florian
Bettina, Heidecker
author_sort Richard, Dannebaum
collection PubMed
description BACKGROUND: Disease progression of subjects with coronavirus disease 2019 (COVID-19) varies dramatically. Understanding the various types of immune response to SARS-CoV-2 is critical for better clinical management of coronavirus outbreaks and to potentially improve future therapies. Disease dynamics can be characterized by deciphering the adaptive immune response. METHODS: In this cross-sectional study we analyzed 117 peripheral blood immune repertoires from healthy controls and subjects with mild to severe COVID-19 disease to elucidate the interplay between B and T cells. We used an immune repertoire Primer Extension Target Enrichment method (immunoPETE) to sequence simultaneously human leukocyte antigen (HLA) restricted T cell receptor beta chain (TRB) and unrestricted T cell receptor delta chain (TRD) and immunoglobulin heavy chain (IgH) immune receptor repertoires. The distribution was analyzed of TRB, TRD and IgH clones between healthy and COVID-19 infected subjects. Using McFadden's Adjusted R2 variables were examined for a predictive model. The aim of this study is to analyze the influence of the adaptive immune repertoire on the severity of the disease (value on the World Health Organization Clinical Progression Scale) in COVID-19. FINDINGS: Combining clinical metadata with clonotypes of three immune receptor heavy chains (TRB, TRD, and IgH), we found significant associations between COVID-19 disease severity groups and immune receptor sequences of B and T cell compartments. Logistic regression showed an increase in shared IgH clonal types and decrease of TRD in subjects with severe COVID-19. The probability of finding shared clones of TRD clonal types was highest in healthy subjects (controls). Some specific TRB clones seems to be present in severe COVID-19 (Figure S7b). The most informative models (McFadden´s Adjusted R2=0.141) linked disease severity with immune repertoire measures across all three cell types, as well as receptor-specific cell counts, highlighting the importance of multiple lymphocyte classes in disease progression. INTERPRETATION: Adaptive immune receptor peripheral blood repertoire measures are associated with COVID-19 disease severity. FUNDING: The study was funded with grants from the Berlin Institute of Health (BIH).
format Online
Article
Text
id pubmed-9106482
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91064822022-05-16 Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19 Richard, Dannebaum Phillip, Suwalski Hosseinali, Asgharian Gracie, Du Zhipei Hai, Lin January, Weiner Holtgrewe, Manuel Charlotte, Thibeault Melina, Müller Xiaomin, Wang Zehra, Karadeniz Jacopo, Saccomanno Jan-Moritz, Doehn Ralf-Harto, Hübner Bernd, Hinzmann Anja, Blüher Sandra, Siemann Dilduz, Telman Norbert, Suttorp Martin, Witzenrath Stefan, Hippenstiel Carsten, Skurk Wolfgang, Poller Leif E, Sander Dieter, Beule Florian, Kurth Toumy, Guettouche Ulf, Landmesser Jan, Berka Khai, Luong Rubelt, Florian Bettina, Heidecker eClinicalMedicine Articles BACKGROUND: Disease progression of subjects with coronavirus disease 2019 (COVID-19) varies dramatically. Understanding the various types of immune response to SARS-CoV-2 is critical for better clinical management of coronavirus outbreaks and to potentially improve future therapies. Disease dynamics can be characterized by deciphering the adaptive immune response. METHODS: In this cross-sectional study we analyzed 117 peripheral blood immune repertoires from healthy controls and subjects with mild to severe COVID-19 disease to elucidate the interplay between B and T cells. We used an immune repertoire Primer Extension Target Enrichment method (immunoPETE) to sequence simultaneously human leukocyte antigen (HLA) restricted T cell receptor beta chain (TRB) and unrestricted T cell receptor delta chain (TRD) and immunoglobulin heavy chain (IgH) immune receptor repertoires. The distribution was analyzed of TRB, TRD and IgH clones between healthy and COVID-19 infected subjects. Using McFadden's Adjusted R2 variables were examined for a predictive model. The aim of this study is to analyze the influence of the adaptive immune repertoire on the severity of the disease (value on the World Health Organization Clinical Progression Scale) in COVID-19. FINDINGS: Combining clinical metadata with clonotypes of three immune receptor heavy chains (TRB, TRD, and IgH), we found significant associations between COVID-19 disease severity groups and immune receptor sequences of B and T cell compartments. Logistic regression showed an increase in shared IgH clonal types and decrease of TRD in subjects with severe COVID-19. The probability of finding shared clones of TRD clonal types was highest in healthy subjects (controls). Some specific TRB clones seems to be present in severe COVID-19 (Figure S7b). The most informative models (McFadden´s Adjusted R2=0.141) linked disease severity with immune repertoire measures across all three cell types, as well as receptor-specific cell counts, highlighting the importance of multiple lymphocyte classes in disease progression. INTERPRETATION: Adaptive immune receptor peripheral blood repertoire measures are associated with COVID-19 disease severity. FUNDING: The study was funded with grants from the Berlin Institute of Health (BIH). Elsevier 2022-05-14 /pmc/articles/PMC9106482/ /pubmed/35600330 http://dx.doi.org/10.1016/j.eclinm.2022.101438 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Richard, Dannebaum
Phillip, Suwalski
Hosseinali, Asgharian
Gracie, Du Zhipei
Hai, Lin
January, Weiner
Holtgrewe, Manuel
Charlotte, Thibeault
Melina, Müller
Xiaomin, Wang
Zehra, Karadeniz
Jacopo, Saccomanno
Jan-Moritz, Doehn
Ralf-Harto, Hübner
Bernd, Hinzmann
Anja, Blüher
Sandra, Siemann
Dilduz, Telman
Norbert, Suttorp
Martin, Witzenrath
Stefan, Hippenstiel
Carsten, Skurk
Wolfgang, Poller
Leif E, Sander
Dieter, Beule
Florian, Kurth
Toumy, Guettouche
Ulf, Landmesser
Jan, Berka
Khai, Luong
Rubelt, Florian
Bettina, Heidecker
Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19
title Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19
title_full Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19
title_fullStr Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19
title_full_unstemmed Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19
title_short Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19
title_sort highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to covid-19
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106482/
https://www.ncbi.nlm.nih.gov/pubmed/35600330
http://dx.doi.org/10.1016/j.eclinm.2022.101438
work_keys_str_mv AT richarddannebaum highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT phillipsuwalski highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT hosseinaliasgharian highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT gracieduzhipei highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT hailin highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT januaryweiner highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT holtgrewemanuel highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT charlottethibeault highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT melinamuller highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT xiaominwang highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT zehrakaradeniz highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT jacoposaccomanno highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT janmoritzdoehn highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT ralfhartohubner highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT berndhinzmann highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT anjabluher highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT sandrasiemann highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT dilduztelman highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT norbertsuttorp highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT martinwitzenrath highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT stefanhippenstiel highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT carstenskurk highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT wolfgangpoller highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT leifesander highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT dieterbeule highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT floriankurth highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT toumyguettouche highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT ulflandmesser highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT janberka highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT khailuong highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT rubeltflorian highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19
AT bettinaheidecker highlymultiplexedimmunerepertoiresequencinglinksmultiplelymphocyteclasseswithseverityofresponsetocovid19